Dr. Molly Gilmartin, a Health Tech investor at AlbionVC, shares her expertise on the evolving health tech landscape. She discusses recent investment trends and how the market is shifting towards AI and holistic care solutions. Gilmartin provides insights on approaching market entry for early-stage companies and the importance of understanding unit economics in health tech ventures. She also contrasts the NHS's digital-first strategy for chronic care with the US system, emphasizing patient engagement and technology's role in enhancing care.